Prof. Magdalena Król had the honor of presenting the project “Macrophage-Based Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer” (MACOV) at the ESGCT 2023 conference. Her presentation took place in front of Iordanis Arzimanoglou, the EIC program manager. This was a unique opportunity to showcase our groundbreaking project, adding a new dimension to the conference. We are excited to be at the forefront of innovative solutions in cancer treatment. Stay tuned for more updates on this topic!